Displaying 1 to 13 of 13 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Fabric7 Inc Provider of enterprise servers that integrate computer and networking technologies. |
United States | N/A |
||
|
|
GlobeImmune Inc Biopharmaceuticals company. |
United States | N/A |
||
|
Kovio Inc Developer of a new category of semiconductor products using printed silicon electronics and thin film technology |
United States | N/A Initial investment. Round participant. Active |
||
|
|
Memory Pharmaceuticals Corp |
United States | N/A |
||
|
NanoGram Corp Maker of core process technology for the manufacture of nanostructured materials for optical, electronic and energy applications |
United States | N/A Active |
||
|
|
NanoGram Corp Maker of core process technology for the manufacture of nanostructured materials for optical, electronic and energy applications |
United States | 15 Jan 2008 | Series C Active |
|
|
|
Renovis Inc |
United States | N/A |
||
|
|
Tolerx Inc Developer of a novel therapies focusing on modulating T-cell activities for treating autoimmune diseases, diabetes, and cancer. |
United States | N/A |
||
|
|
Trevena Inc |
United States | N/A Active |
||
|
|
Trevena Inc |
United States | 10 May 2013 | Series C Active |
|
|
Ubiquisys Ltd Developer of convergence solutions that enable mobile operators to speed up and fully benefit from fixed mobile substitution |
United Kingdom | 12 Jul 2010 | Venture Initial investment. Round participant. Exited (Trade sale) |
|
|
|
Ubiquisys Ltd Developer of convergence solutions that enable mobile operators to speed up and fully benefit from fixed mobile substitution |
United Kingdom | 15 Aug 2012 | Venture Follow-on investment. Round participant. Exited (Trade sale) |
|
|
|
Xanthus Pharmaceuticals Inc |
United Kingdom | N/A |